Skip to content

Clinical trials

Phase 1/2 Scleroderma, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 1/2 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20072
20082
20091
20111
20121
20142
20152
20172
20181
20211
20221
20233
20247
20254
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Completed13
Not yet recruiting5
Unknown status5
Terminated3
Withdrawn1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Beijing GoBroad Hospital2
Peking University Third Hospital2
Stanford University2
University Hospital, Grenoble2
University of California, Los Angeles2
Artgen Biotech1
Boston University1
Essen Biotech1
Fate Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic41
Scleroderma, Diffuse15
Lupus Erythematosus, Systemic7
Myositis7
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis5
Arthritis, Rheumatoid5
Autoimmune Diseases5
Lupus Nephritis4
Dermatomyositis3
Sjogren's Syndrome3

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.